HD-OPM Archive
Topics › Statins

Meta-analysis: statin use linked to 20% lower dementia and 32% lower Alzheimer's risk

Louis Nervegna · Dec 15, 2024 · ♥ 11 reactions · 1 comments · original Facebook post
StatinsBrain health & dementia
↻ This is a repost. The main version (highest ranked) is Statin use linked to 20% lower dementia and 32% lower Alzheimer's risk in meta-analysis · Oct 22, 2024.
AI summary & key facts

Louis cites a large meta-analysis of observational studies showing statin use associated with lower dementia (36 studies) and Alzheimer's (21 studies) risk. The authors conclude it confirms no neurocognitive risk from statins and suggests a possible neuroprotective role, which RCTs would need to test.

(no text — see the shared post below)

Research cited

In a huge meta-analysis of observational studies, statin use was associated with a 20% lower risk of dementia (36 studies), and a 32% lower risk of Alzheimer’s (21 studies).

Quoted:

“In the pooled analyses, statins were associated with a decreased risk of dementia [36 studies, OR 0.80 (CI 0.75–0.86)] and of AD [21 studies, OR 0.68 (CI 0.56–0.81)].”

“These results confirm the absence of a neurocognitive risk associated with statin treatment and suggest a potential favourable role of statins. Randomized clinical trials with an ad hoc design are needed to explore this potential neuroprotective effect.”

#statinsdementiaHD #ldldementiaHD #statinsHD #dementiaHD #alzheimersHD

← newer: Statin muscle toxicity overstated: rhabdomyolysis ~1 in 100,older: High LDL does not protect the brain: 2024 Lancet Commission →